Endymed Ltd (ENDY.TA)
Endymed Ltd operates in the Medical - Devices industry of the Healthcare sector, headquartered in Freehold, NJ, US. The stock last traded at $320.10, up 0.00% on the session, giving a market capitalisation of $44.1M. Its beta of -0.29 implies it has historically moved less than the broad market.
Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Endymed Ltd is most often compared with the following Healthcare names: